Antihypertensive Meds and Depression Risk Examined
Depression rates down with nine antihypertensive agents, including enalapril, amlodipine, atenolol
Psychosis
Pimavanserin sNDA Under Review for Dementia-Related Psychosis
The FDA has accepted for filing the supplemental New Drug Application (sNDA) for pimavanserin (Nuplazid®; Acadia) for the treatment of hallucinations and delusions associated with dementia-related psychosis.
Sublingual Dexmedetomidine Promising for Acute Agitation With Schizophrenia, Bipolar Disorder
Dexmedetomidine is currently available as a solution for intravenous infusion for use in clinical anesthesia and sedation in an intensive care setting.
Phase 3 Trial Evaluating Roluperidone in Schizophrenia Misses End Points
Minerva Neurosciences announced that its phase 3 trial of roluperidone (MIN-101) did not meet the primary and key secondary end points for the treatment of negative symptoms in schizophrenia.
Aristada, Vivitrol Access Expanded During COVID-19 Pandemic
Alkermes has decided to expand the number of retail pharmacies and clinics where patients can receive access to Aristada (aripiprazole lauroxil) and Vivitrol (naltrexone extended-release injectable suspension).
Secuado Transdermal System Now Available for Schizophrenia
The approval was supported by data from a 6-week, phase 3, double-blind, placebo-controlled, fixed-dose study that compared the efficacy and safety of Secuado 3.8mg/24 hours and 7.6mg/24 hours to placebo in 616 adult patients with schizophrenia.
First Generic Version of Geodon for Injection Now Available
Dr. Reddy’s Laboratories announced the launch of Ziprasidone Mesylate for Injection, the generic equivalent of Geodon for Injection (Pfizer).
FDA Bans Electrical Stimulation Devices for Self-Injurious, Aggressive Behavior
The use of electrical stimulation devices (ESDs) to treat self-injurious or aggressive behavior has been banned by the Food and Drug Administration (FDA).
Antipsychotic Initiation Ups Risk for Head Injury, TBI in Alzheimer Disease
TBI injury risk up for quetiapine versus risperidone users.
New Drugs Approved in 2019
This slideshow gives you an at-glance view of all the new drug approvals in 2019. For the latest drug approvals visit our New Drug Products page.
